Intrauterine contraception in nulliparous women: why ever not?
نویسندگان
چکیده
Gynaecology Forum Vol. 16, No. 1, 2011 © 2011 Medical Forum International 24 3. Sääv I, Aronsson A, Marions L, et al. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod 2007; 22: 2647–52. 4. Suhonen S, Haukkamaa M, Jakobsson T, et al. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 2004; 69: 407–12. 5. Harris M, Kaneshiro B. An evidence-based approach to hormonal contraception and headaches. Contraception 2009; 80(5): 417–21. 6. Rogovskaya S, Rivera R, Grimes DA, et al. Effect of a levonorgestrel intrauterine system on women with type 1 diabetes: a randomized trial. Obstet Gynecol 2005; 105(4): 811–15. 7. Rönnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. Acta Obstet Gynaecol Scand 1999; 78: 716–21. 8. Morin-Papunen L, Martikainen H, McCarthy MI, et al. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrelreleasing intrauterine device in a general population. Am J Obstet Gynecol 2008; 199(5): 529.e1–e10. 9. Langlois MR, Rietzschel ER, De Buyzere ML, et al.; the Asklepios Investigators. Femoral plaques confound the association of circulating oxidized low-density lipoprotein with carotid atherosclerosis in a general population aged 35 to 55 years. Arterioscler Thromb Vasc Biol 2008; 28: 1563. 10. ACOG Committee on Practice Bulletins–Gynecology. ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 2006; 107(6): 1453–72. 11. Kaunitz A, Meredith S, Inki P, et al. Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis. Obstet Gynecol 2009; 113: 1104–16. 12. Silverberg SG, Haukkamaa M, Arko H, et al. Endometrial morphology during long-term use of the levonorgestrel-releasing intrauterine device. Int J Gynaecol Pathol 1986; 5: 235–41. 13. Andersson K, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1990; 97: 690–4. 14. Scholten PC, Christiaens GCML, Haspels AA. Treatment of menorrhagia by intrauterine administration of levonorgestrel. In: Scholten PC. The levonorgestrel IUD. Clinical performance and impact on menstruation [dissertation]. Utrecht: University of Utrecht, 1989. 15. Depypere HT, Hillard T, Erkkola R, et al. A 60-month noncomparative study on bleeding profiles with the levonorgestrel intrauterine system from the late transition period to estrogen supplemented menopause. Eur J Obstet Gynecol Reprod Biol 2010; 153(2): 176–80.
منابع مشابه
Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women.
Two intrauterine devices (IUDs) are available in the United States, the levonorgestrel-bearing intrauterine system (Mirena) and the copper-bearing T380A (Paragard). These devices have very low typical-use failure rates but are used by only a minority of women. In particular, there is concern about their use in nulliparous women. We review the available data to address common concerns about usin...
متن کاملNew intrauterine technologies for contraception and treatment in nulliparous/adolescent and parous women
The IUD (intra uterine device) is a highly effective method of contraception that is underused. New developments in intrauterine technology, smaller frameless copper and levonorgestrel-releasing devices, could help increase the prevalence-- of use in adolescents and nulliparous women. Because adolescents and young nulliparous women contribute disproportionately to the epidemic of unintended pre...
متن کاملNitrous Oxide for Pain Management of Intrauterine Device Insertion in Nulliparous Women
IUDs are exceptional methods of contraception. They do not require daily use and are, therefore, “forgettable” and yet also boast very low failure rates. Women are increasingly interested in these methods of contraception. Yet, evidence has shown that nulliparous women may experience more pain than multiparous women at the time of IUD insertion, typically a moderate pain level. This pain may pr...
متن کاملIntrauterine device quo vadis? Why intrauterine device use should be revisited particularly in nulliparous women?
Background Long-acting reversible contraceptive (LARC) methods, including intrauterine devices (IUDs) and the contraceptive implant, are considered the best methods for preventing unintended pregnancies, rapid repeat pregnancy, and abortion in young women. An opinion paper of 2012 by the American College of Obstetricians and Gynecologists recommends Mirena and Paragard for use in nulliparous an...
متن کامل[Intrauterine contraception in nulliparous women as a strategy to reduce unplanned pregnancies in Latin America].
UNLABELLED Due high rates of unplanned pregnancy and unsafe abortion in young women in Latin America intrauterine contraception, by its great contraceptive efficacy, should be offered by the public services of health in a more generalized way. However, some negative prejudices prevail over the perception of its benefits. The aim of this article was to explore the most relevant myths around this...
متن کامل